-
Disparities in Market Access of ATMPs: A Comparative Analysis of HTA Outcomes Across Europe
Sep 9, 2025, 16:22 PM -
Utility Values for Dementia in Finland and Spain
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis for an Efficacy Assessment of Avelumab Axitinib in the First-Line Treatment of International Metastatic RCC Database Consortium (IMDC) Favorable Risk Patients With Advanced Renal Cell Carcinoma (ARCC)
Sep 9, 2025, 16:22 PM -
Multimorbidity and Health-Related Quality of Life Among Adult Population in the United States
Sep 9, 2025, 16:22 PM -
Qualitative Assessment of Women’s Experiences of Sleep Disturbances Associated With Menopause to Evaluate Content Validity of Patient-Reported Outcomes
Sep 9, 2025, 16:22 PM -
Economic and Clinical Impact of Advanced Therapies in Moderate-to-Severe Rheumatoid Arthritis in Spain: CIARA Study
Sep 9, 2025, 16:22 PM -
Value of the France Early Access Pathways: Highlighting Benefits for Patients and Industry Sponsors of the Novel Therapeutic Fosmanogepix Addressing High Unmet Clinical Needs in Invasive Fungal Infections
Sep 9, 2025, 16:22 PM -
Addressing Clinical Uncertainties in ATMP Reimbursement: A Review of European Methodological Guidelines and Practices
Sep 9, 2025, 16:22 PM -
Preferences for a Combination Influenza and COVID-19 Vaccine: Results From a Stated-Preference Survey With Consumers in the United States, United Kingdom, and Germany
Sep 9, 2025, 16:22 PM -
EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)
Sep 9, 2025, 16:22 PM -
Reference Framework, Key Decision-Making Factors, and the Impact of Critical Parameters on Listing Recommendations for Nononcologic Drugs for Rare Diseases Issued by Canadian HTA Bodies
Sep 9, 2025, 16:22 PM -
Systematic Review on the Association of Loneliness and Social Isolation With Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Cost of Care for Relapsing/Remitting Multiple Sclerosis Treatments: A Pharmacoeconomic Evaluation From the Spanish Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Quantifying the Societal Value: Reduced Burden and Resource Savings From Baloxavir Marboxil's Influenza Transmission Protection in China
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ribociclib Plus Endocrine Therapy for the Treatment of HR/HER2 Early Breast Cancer in Greece
Sep 9, 2025, 16:22 PM -
Assessing the Sensitivity of EQ-5D-5L and AQoL-4D to Disease Severity in Von Willebrand Disease: Findings From UK Cohort of the PIVOT-vWD Study
Sep 9, 2025, 16:22 PM -
Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States
Sep 9, 2025, 16:22 PM -
Utilization of Real-World Evidence (RWE) in AMNOG Dossiers Following the 2024 GBA Revision of Module 3 Requirements
Sep 9, 2025, 16:22 PM -
Infective Endocarditis Following FRANCE-TAVI Insights
Sep 9, 2025, 16:22 PM -
Unmet Need and the Public Health Grant: A Data-Driven Tool for Local Authority Spending Decisions
Sep 9, 2025, 16:22 PM
